Edition:
United Kingdom

Sun Pharmaceutical Industries Ltd (SUN.NS)

SUN.NS on National Stock Exchange of India

411.25INR
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
Rs411.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
9,558,071
52-wk High
Rs679.30
52-wk Low
Rs401.50

Chart for

About

Sun Pharmaceutical Industries Limited is a pharmaceuticals company. The Company's business segments include US Business, Indian Branded Generics Business, Emerging Markets, Global Consumer Healthcare Business and Active Pharmaceutical Ingredients (API). Its Rest of World segment includes Western Europe, Canada, Australia, New... (more)

Overall

Beta: 0.05
Market Cap(Mil.): Rs1,272,113.00
Shares Outstanding(Mil.): 2,399.31
Dividend: 3.50
Yield (%): 0.66

Financials

  SUN.NS Industry Sector
P/E (TTM): 28.37 31.13 33.63
EPS (TTM): 18.69 -- --
ROI: -- 15.55 15.02
ROE: -- 16.92 16.60

Indian shares at 1-week closing low; cenbank keeps rates on hold

Dec 5 Indian shares hit a one-week closing low on Wednesday after the country's central bank left interest rates unchanged, while resurgent trade worries dented global sentiment.

05 Dec 2018

India's Sun Pharma tumbles after report of probe

Dec 3 Shares of India's Sun Pharmaceutical Industries sank more than 10 percent on Monday after a report of a regulatory probe against the country's biggest drug manufacturer by market value.

03 Dec 2018

UPDATE 1-Indian drugmaker Sun Pharma swings to surprise quarterly loss

Nov 13 Sun Pharmaceutical Industries was sent to an unexpected second-quarter loss by a one-off charge for an antitrust litigation settlement.

13 Nov 2018

India's Sun Pharma posts surprise quarterly loss on one-time charge

Nov 13 Sun Pharmaceutical Industries Ltd , India's largest drugmaker by market capitalisation, posted a surprise quarterly loss on Tuesday, hurt by a one-time charge due to a legal settlement.

13 Nov 2018

Morning News Call - India, August 16

To access the newsletter, click on the link: http://share.thomsonreuters.com/assets/newsletters/Indiamorning/MNC_IN_08162018.pdf If you would like to receive this newsletter via email, please register at: https://forms.thomsonreuters.com/india-morning/ FACTORS TO WATCH 11:30 am: Banking Secretary Rajiv Kumar at launch of Canara Bank’s digital branch in New Delhi. LIVECHAT - BONDS UPDATE Reuters interest rate reporter Dhara Ranasinghe delves into gove

16 Aug 2018

UPDATE 1-India's Sun Pharma Q1 profit beats estimates as U.S. sales climb

* Stock top gainer on NSE index (Adds details on U.S. and India sales, share movement)

14 Aug 2018

India's Sun Pharma quarterly profit beats estimates

Aug 14 India's largest drugmaker Sun Pharmaceutical Industries Ltd posted a first-quarter profit on Tuesday, beating street estimates.

14 Aug 2018

India's Sun Pharma says U.S. FDA clears Halol plant

MUMBAI, June 12 India's largest drugmaker Sun Pharmaceutical Industries Ltd said on Tuesday the U.S. Food and Drug Administration (FDA) cleared its Halol drug plant, which had been under supply restrictions due to quality control failures.

12 Jun 2018

Earnings vs. Estimates